Related Experiment Video
Updated: Apr 14, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Suspected autoimmune hepatitis and primary biliary cirrhosis unmasked by interferon-beta in a multiple sclerosis
Kaarina Kowalec1, Eric M Yoshida2, Anthony Traboulsee3
1Neuroscience Program, University of British Columbia (UBC), Vancouver, Canada; Child & Family Research Institute, Vancouver, Canada; Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, Canada.
Abstract:
The use of interferon-beta in multiple sclerosis is associated with various forms of hepatotoxicity, including autoimmune hepatitis and liver failure. We describe a case with features of autoimmune liver disease and primary biliary cirrhosis occurring during long-term treatment with interferon-beta in a patient with relapsing-remitting multiple sclerosis. This case highlights the importance of monitoring biochemical liver test results throughout interferon-beta treatment of multiple sclerosis.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Inhibitors of Viral Protein Synthesis
Hepatitis

